OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’
C. Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
European Journal of Cancer (2020) Vol. 135, pp. 1-7
Closed Access | Times Cited: 28
C. Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
European Journal of Cancer (2020) Vol. 135, pp. 1-7
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Delivering precision oncology to patients with cancer
Joaquı́n Mateo, Lotte Steuten, Philippe Aftimos, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 658-665
Closed Access | Times Cited: 247
Joaquı́n Mateo, Lotte Steuten, Philippe Aftimos, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 658-665
Closed Access | Times Cited: 247
Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review
Theresia Pichler, Friederike Mumm, Navdeep Dehar, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 7
Theresia Pichler, Friederike Mumm, Navdeep Dehar, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 7
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
Olga Bogatyrova, Johanna Sofia Margareta Mattsson, Edith Ross, et al.
European Journal of Cancer (2021) Vol. 151, pp. 136-149
Open Access | Times Cited: 38
Olga Bogatyrova, Johanna Sofia Margareta Mattsson, Edith Ross, et al.
European Journal of Cancer (2021) Vol. 151, pp. 136-149
Open Access | Times Cited: 38
MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making
Patrick Metzger, Maria Elena Hess, Andreas Blaumeiser, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3456-3456
Open Access | Times Cited: 15
Patrick Metzger, Maria Elena Hess, Andreas Blaumeiser, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3456-3456
Open Access | Times Cited: 15
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis
Niklas Gremke, Fiona R. Rodepeter, Julia Teply‐Szymanski, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1561-1561
Open Access | Times Cited: 4
Niklas Gremke, Fiona R. Rodepeter, Julia Teply‐Szymanski, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1561-1561
Open Access | Times Cited: 4
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean
Gustavo Werutsky, Carlos H. Barrios, Andrés F. Cardona, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 11, pp. e488-e500
Closed Access | Times Cited: 26
Gustavo Werutsky, Carlos H. Barrios, Andrés F. Cardona, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 11, pp. e488-e500
Closed Access | Times Cited: 26
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine
Peter Horak, Jonas Leichsenring, Hannah Goldschmid, et al.
Genes Chromosomes and Cancer (2021) Vol. 61, Iss. 6, pp. 303-313
Open Access | Times Cited: 24
Peter Horak, Jonas Leichsenring, Hannah Goldschmid, et al.
Genes Chromosomes and Cancer (2021) Vol. 61, Iss. 6, pp. 303-313
Open Access | Times Cited: 24
Personalisierte Onkologie 2024 – die Sicht der AIO
Annalen Bleckmann, Anke Reinacher‐Schick, C. Benedikt Westphalen
Forum (2025)
Closed Access
Annalen Bleckmann, Anke Reinacher‐Schick, C. Benedikt Westphalen
Forum (2025)
Closed Access
Next-generation diagnostics for precision oncology: Preanalytical considerations, technical challenges, and available technologies
Wencke Walter, Nicole Pfarr, Manja Meggendorfer, et al.
Seminars in Cancer Biology (2020) Vol. 84, pp. 3-15
Closed Access | Times Cited: 26
Wencke Walter, Nicole Pfarr, Manja Meggendorfer, et al.
Seminars in Cancer Biology (2020) Vol. 84, pp. 3-15
Closed Access | Times Cited: 26
Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
Lorraine Portelance, Stefanie Corradini, Bradley A. Erickson, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Lorraine Portelance, Stefanie Corradini, Bradley A. Erickson, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice
S. Bruz̆as, Sherko Kuemmel, Hakima Harrach, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4564-4564
Open Access | Times Cited: 13
S. Bruz̆as, Sherko Kuemmel, Hakima Harrach, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4564-4564
Open Access | Times Cited: 13
Precision oncology and molecular tumor boards
Elisabeth Mack, Peter Horak, Stefan Fröhling, et al.
Deleted Journal (2024) Vol. 65, Iss. 5, pp. 462-471
Closed Access | Times Cited: 1
Elisabeth Mack, Peter Horak, Stefan Fröhling, et al.
Deleted Journal (2024) Vol. 65, Iss. 5, pp. 462-471
Closed Access | Times Cited: 1
A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening
Onat Kadioglu, Faranak Bahramimehr, Mona Dawood, et al.
Computers in Biology and Medicine (2023) Vol. 157, pp. 106781-106781
Closed Access | Times Cited: 3
Onat Kadioglu, Faranak Bahramimehr, Mona Dawood, et al.
Computers in Biology and Medicine (2023) Vol. 157, pp. 106781-106781
Closed Access | Times Cited: 3
Consensus Statements on Precision Oncology in the China Greater Bay Area
Tai-Chung Lam, William C. Cho, Joseph S. K. Au, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 2
Tai-Chung Lam, William C. Cho, Joseph S. K. Au, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 2
Varianteninterpretation in der molekularen Pathologie und Onkologie
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 369-379
Closed Access | Times Cited: 5
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 369-379
Closed Access | Times Cited: 5
Sektorenübergreifende interdisziplinäre Zusammenarbeit der Arbeitsgemeinschaft Internistische Onkologie in der Präzisionsonkologie
C. Benedikt Westphalen, Michael Quante, Bärbel Söhlke, et al.
Der Onkologe (2022) Vol. 28, Iss. S1, pp. 6-16
Closed Access | Times Cited: 1
C. Benedikt Westphalen, Michael Quante, Bärbel Söhlke, et al.
Der Onkologe (2022) Vol. 28, Iss. S1, pp. 6-16
Closed Access | Times Cited: 1
Molekulare Tumorboards – Einblicke und Ausblicke
Silke Laßmann, Michael Hummel
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 357-362
Closed Access | Times Cited: 1
Silke Laßmann, Michael Hummel
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 357-362
Closed Access | Times Cited: 1
[Next generation sequencing in histopathology : Applications and methodological challenges].
Ulrich Lehmann, Andreas Jung
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 363-368
Closed Access | Times Cited: 1
Ulrich Lehmann, Andreas Jung
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 363-368
Closed Access | Times Cited: 1
Precision oncology for upper GI cancers – Where are we heading?
Michael Quante
Translational Oncology (2021) Vol. 16, pp. 101319-101319
Open Access | Times Cited: 1
Michael Quante
Translational Oncology (2021) Vol. 16, pp. 101319-101319
Open Access | Times Cited: 1
Next Generation Sequencing in der Pathologie
Ulrich Lehmann, Andreas Jung
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 363-368
Closed Access | Times Cited: 1
Ulrich Lehmann, Andreas Jung
Der Pathologe (2021) Vol. 42, Iss. 4, pp. 363-368
Closed Access | Times Cited: 1
Precision Oncology: Grundlagen und Klassifikationen
Melanie Boerries, Anna Lena Illert
Springer Reference Medizin (2023), pp. 1321-1327
Closed Access
Melanie Boerries, Anna Lena Illert
Springer Reference Medizin (2023), pp. 1321-1327
Closed Access
Precision oncology in Germany—transsectoral networking for the benefit of patients
Kathrin Heinrich, Thomas Seufferlein, Anke Reinacher‐Schick, et al.
Deleted Journal (2023) Vol. 29, Iss. 10, pp. 889-895
Closed Access
Kathrin Heinrich, Thomas Seufferlein, Anke Reinacher‐Schick, et al.
Deleted Journal (2023) Vol. 29, Iss. 10, pp. 889-895
Closed Access
Molecular profiling—ready for clinical routine
Armin Gerger
memo - Magazine of European Medical Oncology (2020) Vol. 13, Iss. 4, pp. 365-366
Open Access
Armin Gerger
memo - Magazine of European Medical Oncology (2020) Vol. 13, Iss. 4, pp. 365-366
Open Access
Precision Medicine
Florian Lordick, Michael Ghadimi, Ines Gockel, et al.
Visceral Medicine (2020) Vol. 36, Iss. 5, pp. 407-410
Open Access
Florian Lordick, Michael Ghadimi, Ines Gockel, et al.
Visceral Medicine (2020) Vol. 36, Iss. 5, pp. 407-410
Open Access
Molekulare Zytologie: Chancen und Herausforderungen
Verena Tischler
Deleted Journal (2022) Vol. 43, Iss. S1, pp. 130-133
Closed Access
Verena Tischler
Deleted Journal (2022) Vol. 43, Iss. S1, pp. 130-133
Closed Access
